Associated Papers
Inherited thrombocytopenias: history, advances and perspectives.
Nurden AT et al.
Haematologica, 2020
MASTL promotes cell contractility and motility through kinase-independent signaling.
Taskinen ME et al.
The Journal of Cell Biology, 2020
The Cell Cycle Checkpoint System MAST(L)-ENSA/ARPP19-PP2A is Targeted by cAMP/PKA and cGMP/PKG in Anucleate Human Platelets.
Kumm EJ et al.
Cells, 2020
Thrombocytopenia-associated mutations in Ser/Thr kinase MASTL deregulate actin cytoskeletal dynamics in platelets.
Hurtado B et al.
The Journal of Clinical Investigation, 2018
[Mutation of ANKRD26 is responsible for thrombocytopenia 2 (THC2) : a family report in China].
Liu XF et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi, 2018
Inherited thrombocytopenias frequently diagnosed in adults.
Balduini CL et al.
Journal of Thrombosis and Haemostasis : Jth, 2013
In vivo inactivation of MASTL kinase results in thrombocytopenia.
Johnson HJ et al.
Experimental Hematology, 2009
FLJ14813 missense mutation: a candidate for autosomal dominant thrombocytopenia on human chromosome 10.
Gandhi MJ et al.
Human Heredity, 2003
Select a paper to view details